| | --- |
| | language: |
| | - en |
| | bigbio_language: |
| | - English |
| | license: cc0-1.0 |
| | bigbio_license_shortname: CC0_1p0 |
| | multilinguality: monolingual |
| | pretty_name: CZI DRSM |
| | homepage: https://github.com/chanzuckerberg/DRSM-corpus |
| | bigbio_pubmed: false |
| | bigbio_public: true |
| | bigbio_tasks: |
| | - TXTCLASS |
| | --- |
| | |
| | # Dataset Card for CZI DRSM |
| |
|
| | ## Dataset Description |
| |
|
| | - **Homepage:** https://github.com/chanzuckerberg/DRSM-corpus |
| | - **Pubmed:** False |
| | - **Public:** True |
| | - **Tasks:** TXTCLASS |
| |
|
| | Research Article document classification dataset based on aspects of disease research. Currently, the dataset consists of three subsets: |
| |
|
| | (A) classifies title/abstracts of papers into most popular subtypes of clinical, basic, and translational papers (~20k papers); |
| |
|
| | - Clinical Characteristics, Disease Pathology, and Diagnosis: |
| | Text that describes (i) symptoms, signs, or ‘phenotype’ of a disease; |
| | (ii) the effects of the disease on patient organs, tissues, or cells; |
| | (iii)) the results of clinical tests that reveal pathology (including |
| | biomarkers); (iv) research that use this information to figure out |
| | a diagnosis. |
| | |
| | - Therapeutics in the clinic: |
| | Text describing how treatments work in the clinic (but not in a clinical trial). |
| | |
| | - Disease mechanism: |
| |
|
| | - Patient-Based Therapeutics: |
| | Text describing (i) Clinical trials (studies of therapeutic measures being |
| | used on patients in a clinical trial); (ii) Post Marketing Drug Surveillance |
| | (effects of a drug after approval in the general population or as part of |
| | ‘standard healthcare’); (iii) Drug repurposing (how a drug that has been |
| | approved for one use is being applied to a new disease). |
| | |
| | (B) identifies whether a title/abstract of a paper describes substantive research into Quality of Life (~10k papers); |
| |
|
| | - [-1] - the paper is not a primary experimental study in rare disease |
| |
|
| | - [0] - the study does not directly investigate quality of life |
| |
|
| | - [1] - the study investigates qol but not as its primary contribution |
| |
|
| | - [2] - the study's primary contribution centers on quality of life measures |
| |
|
| | (C) identifies if a paper is a natural history study (~10k papers). |
| |
|
| | - [-1] - the paper is not a primary experimental study in rare disease |
| |
|
| | - [0] - the study is not directly investigating the natural history of a disease |
| |
|
| | - [1] - the study includes some elements a natural history but not as its primary contribution |
| |
|
| | - [2] - the study's primary contribution centers on observing the time course of a rare disease |
| | |
| | These classifications are particularly relevant in rare disease research, a field that is generally understudied. |
| | |
| | This data was compiled through the use of a gamified curation approach based on CentaurLabs' 'diagnos.us' platform. |
| |
|
| | ## Citation Information |
| |
|
| | ``` |
| | # N/A |
| | ``` |
| |
|
